Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 224-116-8 | CAS number: 4203-89-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From 21 JAN 2022 to 1 MAR 2022
- Reliability:
- 1 (reliable without restriction)
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 022
- Report date:
- 2022
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Version / remarks:
- 2016
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- mammalian erythrocyte micronucleus test
Test material
- Reference substance name:
- 2-(1-oxa-4-azaspiro[4.5]dec-4-yl)ethyl methacrylate
- EC Number:
- 224-116-8
- EC Name:
- 2-(1-oxa-4-azaspiro[4.5]dec-4-yl)ethyl methacrylate
- Cas Number:
- 4203-89-8
- Molecular formula:
- C14H23NO3
- IUPAC Name:
- 2-{1-oxa-4-azaspiro[4.5]decan-4-yl}ethyl 2-methylprop-2-enoate
- Test material form:
- liquid
- Remarks:
- Pale yellow slightly viscous liquid
- Details on test material:
- Chem. Name: 2-(1-oxa-4-azaspiro[4.5]dec-4-yl)ethyl methacrylate;
CAS 4203-89-8
Batch number: 2110501010
Date of CoA: 08.12.2021
appearance: pale yellow slightly viscous liquid
Mw: 253.34
Purity info: 95%
Production date 5 Oct 2021
expiry date: 5 Oct 2024
Storage: dry; refrigerator between 0 and 5°C
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Details on species / strain selection:
- Han Wistar
Charles River (UK) Ltd., Margate, UK / Envigo, Blackthorn, UK (as available). - Sex:
- male
- Details on test animals or test system and environmental conditions:
- Age range: 7-9 weeks on the first day of dosing
Approximate supplier weight range for 7-9 week animals:
Males: 175-375 g
Females: 125-250 g
RF in 3 male and 3 female showed no substantial differences in toxicity between the sexes, and male animals were selected for the main study.
Environment:
Housing: Wire topped, solid bottom cages.
Cages conforming to the 'Code of Practice for the Housing and Care of Animals Bred, Supplied or Used for Scientific Purposes’ (Home Office, London, 2014).
Housing Density Up to three animals per cage, with sexes separated.
Target Temperature Range: 19 to 25°C
Target Humidity Range: 40 to 70%
Air Changes: minimum of 15 air changes/hour.
Photo-Period 12 hours nominal.
Diet: Ad libitum access to 5LF2 EU Rodent Diet.
Water: Ad libitum access to mains water via water bottles.
Bedding: Suitable wood bedding (Aspen) changed weekly.
Environmental Enrichment: Wooden Aspen chew blocks and rodent retreats.
Analysis and Certification:
- Diet and bedding - per batch (reviewed prior to use).
- Water – periodic analysis.
- Environmental enrichment – as available.
No contaminants are expected to be present in diet, water or bedding at levels which might interfere with achieving the objective of the study. Results of analyses performed on diet, water, bedding and environmental enrichment are held centrally at Labcorp Laboratories.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- Arachis Oil (The vehicle was used with this compound in previous in vivo studies. )
- Details on exposure:
- Method of Preparation: Developed at Labcorp.
Frequency of Preparation: Once.
Stability: The test article formulation in vehicle at 12.5 and 250 mg/mL is stable for 20 days when stored at 2 to 8°C, protected from light (Envigo Study number RM34VX).
Homogeneity: The test article formulation in vehicle is homogeneous at 3.75 and 250 mg/mL (Envigo Study number RM34VX).
Storage Conditions in Dispensary: 2 to 8°C, protected from light.
Dose levels:
RF: (3 male & 3 female): 2000 mg/kg /day, in 10 mL/kg
Main Experiment in 6 males/group: 0, 500, 1000 and 2000 mg/kg/day; in 10 mL/kg
Oral by gavage (unfasted animals). Two administrations, at 0 and 24 hours. - Duration of treatment / exposure:
- Two administrations on day 1 and day 2 (at 0 and 24 hours); necropsy day 3 (48 hours)
- Frequency of treatment:
- Two administrations, at 0 and 24 hours.
- Post exposure period:
- Animals sampled at approximately 48 hours.
Doses / concentrationsopen allclose all
- Dose / conc.:
- 0 mg/kg bw/day (actual dose received)
- Remarks:
- Vehicle control
- Dose / conc.:
- 500 mg/kg bw/day (actual dose received)
- Dose / conc.:
- 1 000 mg/kg bw/day (actual dose received)
- Dose / conc.:
- 2 000 mg/kg bw/day (actual dose received)
- No. of animals per sex per dose:
- 6 males/group
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- Three positive control slides from animals dosed with cyclophosphamide (prepared under Labcorp study 8449759) were stained and analysed alongside the study slides.
These slides were used to verify adequate slide staining of the micronuclei and confirm the ability of the slide analyst to detect a positive response within a coded system.
Examinations
- Tissues and cell types examined:
- One femur were removed and bone marrow isolated from all animals at scheduled kill.
Slides were prepared from cell suspension from bone marrow. - Details of tissue and slide preparation:
- Bone Marrow Isolation: Flushed from femur with foetal bovine serum.
Sample Filtration: Additional foetal bovine serum was added to sample prior to filtration through cellulose column (Sun et al., 1999).
Cell Suspension: Cells pelleted by centrifugation. Supernatant decanted and pellet resuspended in serum. Centrifugation repeated and majority of supernatant decanted.
Number of Slides: At least 3.
Slide Preparation: Pellet gently resuspended in remaining serum. Smears made on microscope slides and air-dried.
Fixation: Absolute methanol.
Staining: At least 1 slide per animal stained, with remaining slides held as reserves.
Fixed slides are rinsed in distilled water, then stained in 12.5 µg/mL acridine orange.
Stained slides were rinsed in phosphate buffer, air-dried and stored in the dark at room temperature prior to analysis. - Statistics:
- MN PCE in the test article treated groups (Groups 2 to 4) and from the positive control slides are compared against the vehicle control group (Group 1) using ranks of the data via the Wilcoxon Rank Sum Test (Lehmann, 1975).
The tests are interpreted with one-sided risk for increased frequency with increasing dose.
A Terpstra-Jonckheere test will be conducted to evaluate dose response (Jonckheere, 1954).
Probability values of p≤0.05 is accepted as significant.
Results and discussion
Test results
- Key result
- Sex:
- male
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Remarks:
- Tested up to maximum dose of 2000 mg/kg bw
- Negative controls validity:
- valid
- Positive controls validity:
- valid
Any other information on results incl. tables
- : NPT 2042: Summary of Bone Marrow 48hr Micronucleus Data – Male
Assay validity:
The vehicle control data (%PCE and MN PCE) were within the laboratory’s historical vehicle control observed data ranges.
The positive control slides demonstrated a statistically significant increase in MN PCE (over the concurrent vehicle control group) that was above the laboratory’s positive control data, but confirmed that micronuclei could be detected under coded scoring conditions and was therefore accepted as valid.
Group/ Dose Level | % PCE | % MN PCE | WRS P-value | Significance | ||
(mg/kg/day) | Mean | SD | Mean | SD | ||
|
|
|
|
|
|
|
1/ Vehicle (0) | 51.03 | 1.48 | 0.06 | 0.05 | N/A | N/A |
2/ Nourycryl MA 128 (500) | 54.73 | 2.94 | 0.08 | 0.05 | 0.3333 | NS |
3/ Nourycryl MA 128 (1000) | 51.27 | 5.45 | 0.10 | 0.04 | 0.1613 | NS |
4/ Nourycryl MA 128 (2000) | 46.37 | 4.81 | 0.10 | 0.08 | 0.2835 | NS |
5/ CPA (10) | 51.00 | 4.69 | 4.94 | 0.28 | 0.0119 | * |
Terpstra-Jonckheere dose response p-value (Groups 1,2,3,4 ): 0.2161 NS |
|
MN Micronucleated
PCE Polychromatic erythrocyte
SD Standard deviation
WRS Wilcoxon Rank Sum Test
NS Not significant (p>0.05)
* p≤0.05
Applicant's summary and conclusion
- Conclusions:
- Nourycryl MA 128 did not induce micronuclei in the polychromatic erythrocytes of the bone marrow when tested up to 2000 mg/kg/day (the maximum recommended dose).
- Executive summary:
Nourycryl MA 128: was tested for its potential to induce micronuclei (MN) in the polychromatic erythrocytes (PCE) of the bone marrow of treated rats.
Strain / Species: Han Wistar Rats
The dose range finding study indicated that 2000 mg/kg/day (the regulatory recommended maximum dose) was tolerated. The main study therefore was performed using 3 groups of 6 male rats that dosed with the test substance at 500, 1000 and 2000 mg/kg bw in 10 mL arachis oil/kg bw in two administrations 24 hours apart. An additional groupd of 6 males received vehicle alone (negative control).
Positive control slides, prepared under Labcorp Study Number 8449759 were stained and coded alongside the study slides.
Evaluations consisted of clinical signs (prior to dosing, immediate, 0.5, 1, 2 and 4-6 hours post dosing on day 1 and 2, and prior to necropsy on day 3) and BW.
Slides prepared from the bone marrow of the femurs of the animals and evaluated for ration polychromatic erythorcytes (PCE) and normochromatic erythrocytes (NCE) and for the presence of micronuclei (MN) in at least 4000 PCE/animal.In the Range-Finder Experiment of this study a group of 3 male and 3 female rats were dosed with Nourycryl MA 128 at a dose level of 2000 mg/kg/day.
On day 1 all animals exhibited decreased activity 0.5 hr and 1 hour post dose. All three female animals had returned to a normal state 2 hours post dose but the three male animals still exhibited decreased activity, which was also noted in 2/3 male animals approximately 4 hours post dose. On day 2 all animals were marked normal prior to dosing. Immediately after dosing salivation was noted in all animals, which persisted up to 1 hour post dose. Decreased activity was noted in all animals from 0.5 hour post dose which lasted throughout the rest of the day. Transient raised fur was noted in 1 female animal 1 hour post dose and 1 male animal 4 hours post dose. A single male was also noted to have staining around the mouth 4 hours post dose. On the morning of Day 3 all animals had returned to a normal state and no clinical signs were noted for any animals throughout the day. The mean % bodyweight changes from Day 1 to Day 3 were -9.9% for the male animals and -6.4% for the female animals.
there are no data available to suggest differences in metabolism or bioavailability, or gender specific exposure. As there were no substantial differences in toxicity between the sexes male animals only were used for the main study.Assay validity was confirmed. The vehicle control data (%PCE and MN PCE) were within the laboratory’s historical vehicle control observed data ranges.
The positive control slides demonstrated a statistically significant increase in MN PCE (over the concurrent vehicle control group) that was above the laboratory’s positive control data, but confirmed that micronuclei could be detected under coded scoring conditions and was therefore accepted as valid.Animals treated with Nourycryl MA 128:
All doses exhibited group mean %PCE that were similar to the concurrent vehicle control group and which fell within the laboratory’s historical vehicle control data, thus confirming there was no evidence of test article related bone marrow toxicity. However, results from earlier OECD 422 study clearly shows that systemic exposures occur. In this study dose levels of 0, 50, 150 and 375 mg/kg bw/day resulted to changes hematology and blood chemistry parameters suggestive of mild anemia, and to liver and kidney effects, resulting to a NOAEL of 50 mg/kg bw/day.All doses exhibited MN PCE frequencies that were similar to the concurrent vehicle control group and that fell within laboratory's historical vehicle control data. There were no statistically significant increases in MN frequency for any of the groups receiving the test article, compared to the concurrent vehicle controls.
It is concluded that Nourycryl MA 128 did not induce micronuclei in the polychromatic erythrocytes of the bone marrow when tested up to 2000 mg/kg/day (the maximum recommended dose), under the experimental conditions employed.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.